# TB-500 Research Guide: Identity, Literature, Analysis and Documentation

> Markdown copy of https://starbio.org/tb-500-research-guide/ for language models and reading tools. The web page is the reference version: cite that address. Page last updated November 12, 2026.
>
> Research use only. StarBio supplies materials for in vitro laboratory research. They are not for human or veterinary use.

*Research use only. StarBio products are supplied strictly for in-vitro laboratory research by qualified professionals. They are not for human or veterinary use, not for diagnostic or therapeutic use, and have not been evaluated by the FDA. This guide covers identity, documentation and handling only. It is not usage guidance.*

TB-500 is the name research catalogues use for a short synthetic peptide: the N-acetylated residues 17 to 23 of thymosin beta-4, Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln. It is a seven-residue fragment, not the 43-residue protein, and the distinction matters when reading the literature. This page collects the identity data, the research areas the thymosin beta-4 literature covers, what to look for on a certificate for this fragment, and the independent reports on file for StarBio lots.

## Identity

| Name | TB-500 (thymosin beta-4 fragment 17-23, acetylated; also written TB500, Tβ4 17-23) |
| --- | --- |
| Type | N-acetylated synthetic heptapeptide |
| CAS number | 885340-08-9 |
| Molecular weight | 889.02 g/mol |
| Formula | C38H68N10O14 |
| Sequence | Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln |
| Length | 7 amino acids |

TB-50010 mg · $39.99For laboratory research use only.

[View product](https://starbio.org/product/tb-500/)

## Origin and history

Thymosin beta-4 is a 43-residue, highly conserved protein first isolated from calf thymus in the early 1980s by Goldstein’s group, and later recognised as the main actin-sequestering peptide in many cell types. The LKKTETQ segment at residues 17 to 23 is its actin-binding motif. The fragment sold as TB-500 reproduces that segment with an acetylated N-terminus. Almost all of the published work cited for this compound, including the reviews listed below [1, 2, 4], was done with the full-length protein, so a reader should treat results on thymosin beta-4 as context for the fragment, not as data about it.

## What the literature covers

The references on file for this compound span several research areas. They are listed here as areas of study, not as results.

- **Basic properties and reviews.** A 2012 review in *Expert Opinion on Biological Therapy* summarises the biochemistry of thymosin beta-4 [1]; a 2010 *Annals of the New York Academy of Sciences* paper surveys the animal literature [2]; a 2023 *International Immunopharmacology* review frames it in regenerative research [4].
- **Ocular surface models.** Work on the cornea and ocular surface, including a bench-to-bedside review (2018) [3], a chapter in *Vitamins and Hormones* (2016) [10] and a bacterial keratitis model (2023) [6].
- **Dermal and tissue models.** A 2016 chapter on dermal models [5] and a 2025 *Advanced Science* paper on engineered extracellular vesicles carrying the protein [8].
- **Cardiac models.** A 2015 review on the mammalian heart [7].
- **Inflammation and autophagy.** A 2018 paper on autophagy pathways [11].
- **Other mammalian tissue models.** A 2023 study on middle ear lesions in adult mammals [9].

Several of these are reviews by the same small group of authors, and the primary studies are animal or cell models of the full protein. Anyone citing TB-500 work should check which molecule a paper actually used.

## Analytical notes

The fragment has no aromatic residue, so it does not absorb at 280 nm; HPLC detection relies on the peptide bond at 210 to 220 nm, and a report should state the wavelength used. Mass spectrometry confirms identity against the theoretical mass for C38H68N10O14; the acetyl group makes the molecule 42 Da heavier than the free heptapeptide, which is one of the impurities worth looking for. With two lysines and two threonines in seven residues, deletion sequences elute close to the parent peak. Lysine-rich peptides are supplied as acetate or trifluoroacetate salts and take up water readily, so HPLC area percent will sit above peptide content by weight; a measured content figure closes that gap (see [what 99% purity means](https://starbio.org/what-99-percent-purity-means/)).

## Storage and stability

- Lyophilized powder
- Store at -20 °C
- Protect from light
- Avoid repeated freeze-thaw cycles
- In solution: 2-8 °C, short term

## Documentation for StarBio lots

Every StarBio lot is analysed by an independent laboratory. The table lists the reports on file for this compound; the Janoshik report reference can be checked against the laboratory’s own record.

| Variant | Laboratory / report | HPLC purity | Labelled / measured | Tested |  |
| --- | --- | --- | --- | --- | --- |
| TB-500 10 mg | Janoshik #136382 | 98.72% | 10 mg / 10.74 mg | Apr 22, 2026 | [report](https://janoshik.com/tests/136382-TB50010mg_4YQGBDING23D) |
| TB-500 5 mg | Medutest WWB-BT5-6830 | 99.50% | 5 mg | Feb 23, 2026 | [report](https://starbio.org/wp-content/uploads/2026/07/coa-medutest-TB-500_TB4_5mg.webp) |

Current certificates are in the [COA Library](https://starbio.org/coa/); the [verify-lot form](https://starbio.org/verify-lot/) connects an order to its batch record.

## References

1. [Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications](https://pubmed.ncbi.nlm.nih.gov/22074294/). Expert Opinion on Biological Therapy, 2012, PMID 22074294.
2. [Animal studies with thymosin beta, a multifunctional tissue repair and regeneration peptide](https://pubmed.ncbi.nlm.nih.gov/20536453/). Annals of the New York Academy of Sciences, 2010, PMID 20536453.
3. [Thymosin beta 4 and the eye: the journey from bench to bedside](https://pubmed.ncbi.nlm.nih.gov/30063853/). Expert Opinion on Biological Therapy, 2018, PMID 30063853.
4. [Thymosin beta-4 denotes new directions towards developing prosperous anti-aging regenerative therapies](https://pubmed.ncbi.nlm.nih.gov/36709593/). International Immunopharmacology, 2023, PMID 36709593.
5. [Thymosin β4 Promotes Dermal Healing](https://pubmed.ncbi.nlm.nih.gov/27450738/). Vitamins and Hormones, 2016, PMID 27450738.
6. [Thymosin beta 4: A potential novel adjunct treatment for bacterial keratitis](https://pubmed.ncbi.nlm.nih.gov/37018981/). International Immunopharmacology, 2023, PMID 37018981.
7. [Thymosin β4: multiple functions in protection, repair and regeneration of the mammalian heart](https://pubmed.ncbi.nlm.nih.gov/26094634/). Expert Opinion on Biological Therapy, 2015, PMID 26094634.
8. [Tβ4-Engineered ADSC Extracellular Vesicles Rescue Cell Senescence Through Separable Microneedle Patches for Diabetic Wound Healing](https://pubmed.ncbi.nlm.nih.gov/40279568/). Advanced Science, 2025, PMID 40279568.
9. [Thymosin beta-4 – A potential tool in healing middle ear lesions in adult mammals](https://pubmed.ncbi.nlm.nih.gov/38706788/). International Immunopharmacology, 2023, PMID 38706788.
10. [Thymosin Beta 4: A Potential Novel Therapy for Neurotrophic Keratopathy, Dry Eye, and Ocular Surface Diseases](https://pubmed.ncbi.nlm.nih.gov/27450739/). Vitamins and Hormones, 2016, PMID 27450739.
11. [Thymosin β4 limits inflammation through autophagy](https://pubmed.ncbi.nlm.nih.gov/30063848/). Expert Opinion on Biological Therapy, 2018, PMID 30063848.

Product page: [TB-500](https://starbio.org/product/tb-500/). Related guides: [BPC-157 research guide](https://starbio.org/bpc-157-research-guide/), [what 99% purity means](https://starbio.org/what-99-percent-purity-means/), [how to read a certificate](https://starbio.org/how-to-read-a-certificate-of-analysis/).

*For laboratory research use only. Not for human or veterinary use.*

Compared with related compounds: [BPC-157 vs TB-500](https://starbio.org/bpc-157-vs-tb-500/).

## Questions about TB-500

### What is TB-500?

TB-500 is a n-acetylated heptapeptide (thymosin beta-4 17-23 fragment): 7 residues (heptapeptide), molecular weight 889.02 g/mol, CAS number 885340-08-9. It is supplied for in vitro laboratory research only. This guide covers identity, documentation and handling, not use.

### Is TB-500 the same as Thymosin beta-4 fragment 17-23 and Ac-LKKTETQ?

TB-500 is also listed as Thymosin beta-4 fragment 17-23 and Ac-LKKTETQ. On a certificate or vial label, the CAS number (885340-08-9) and the sequence identify the material regardless of which name is used.

### What are the CAS number, formula and molecular weight of TB-500?

TB-500 has CAS number 885340-08-9, molecular formula C38H68N10O14 and molecular weight 889.02 g/mol. Sequence: Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln. Identity of each StarBio batch is confirmed by mass spectrometry on the laboratory report.

### Is StarBio's TB-500 independently tested?

Yes. The current TB-500 batch was tested by Janoshik Analytical (Janoshik Analytical report #136382): 98.72% purity by HPLC, measured content 10.74 mg against 10 mg labelled, tested Apr 22, 2026. The report is on file in the [COA library](https://starbio.org/coa/) ([report page](https://starbio.org/coa/tb-500-tb4-10-mg-janoshik-136382/)). Janoshik Analytical reports can be checked on janoshik.com with the report number.

### How should TB-500 be stored?

Lyophilized powder; Store at -20 °C; Protect from light; Avoid repeated freeze-thaw cycles; In solution: 2-8 °C, short term. StarBio ships it as sealed lyophilized powder.

### Where can I buy TB-500 for laboratory research?

StarBio sells [TB-500](https://starbio.org/product/tb-500/) as 10 mg at $39.99, shipped tracked from Florida to all 50 US states. StarBio does not ship internationally. Buyers must be qualified researchers or institutions aged 21 or older, buying for in vitro laboratory work.

---

StarBio: https://starbio.org/ | Site summary for language models: https://starbio.org/llms.txt | Laboratory report data: https://starbio.org/coa.json
